1Rodeghiero F,Stasi R,Gemsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113 (11):2386-2393.
2Harrington WJ,Minnich V,Hollingsworth J W,et al.Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura[J].J Lab Clin Med,1951,38 (1):1-10.
3Hamidpour M,Behrendt M,Griffiths B,et al.The isolation and characterization of antiplatelet antibodies[J].Eur J Haematol,2006,76 (4):331-338.
4Olsson B,Ridell B,Jernas M,et al.Increased number of B-cells in the red pulp of the spleen in ITP[J].Ann Hematol,2012,91 (2):271-277.
5Zhu X J,Shi Y,Peng J,et al.The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia[J].Blood,2009,114 (26):5362-5367.
6Kuwana M,Kawakami Y,Ikeda Y.Suppression of autoreactive T-cell response to glycoprotein Ⅱb/Ⅲa by blockade of CD40/CD154 interaction:implications for treatment of immune thrombocytopenic purpura[J].Blood,2003,101 (2):621-623.
7Zhou B,Zhao H,Yang R C,et al.Multi-dysfunctional pathophysiology in ITP[J].Crit Rev Oncol Hematol,2005,54 (2):107-116.
8Guo C,Chu X,Shi Y,et al.Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura[J].J Clin Immunol,2007,27 (6):557-562.
9Sakaguchi S,Miyara M,Costantino C M,et al.FOXP^3 + regulatory T cells in the human immune system[J].Nat Rev Immunol,2010,10 (7):490-500.
10David R.Regulatory T cells:A helping hand from Bacteroides fragilis[J].Nat Rev Immunol,2010,10(8):539.
